Showing results (121-130 of 387) with videos related to

Sort By:
Pageof 39
Inflammatory Bowel Diseases|July 11, 2013
Virtual chromoendoscopy for prediction of severity and disease extent in patients with inflammatory bowel disease: a randomized controlled studyHelmut Neumann, Michael Vieth, Claudia Günther, et al.
World Journal of Gastroenterology|April 16, 2019
Comparison of Hemospray® and Endoclot™ for the treatment of gastrointestinal bleedingFrancesco Vitali, Andreas Naegel, Raja Atreya, et al.
Endoscopy|April 12, 2007
In-vivo microvascular imaging of early squamous-cell cancer of the esophagus by confocal laser endomicroscopyK Deinert, R Kiesslich, M Vieth, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|July 8, 2020
COVID-19 - more than respiratory disease: a gastroenterologist's perspectiveP C Konturek, I A Harsch, M F Neurath, et al.
Inflammatory Bowel Diseases|July 11, 2022
Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T CellsAnna Schweda, Emily Becker, Maximilian Wiendl, et al.
Frontiers in Immunology|February 22, 2021
CCR8 Signaling via CCL1 Regulates Responses of Intestinal IFN-γ Producing Innate Lymphoid CelIs and Protects From Experimental ColitisLe Kang, Angelika Schmalzl, Tamara Leupold, et al.
Zeitschrift Fur Gastroenterologie|September 26, 2002
Functional relevance of soluble TNF-alpha, transmembrane TNF-alpha and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseasesM H Holtmann, M Schütz, P R Galle, et al.
Inflammatory Bowel Diseases|August 9, 2022
Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic TreatmentYoram Bouhnik, Raja Atreya, Daniel Casey, et al.
Nature Medicine|September 1, 1996
Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in miceM F Neurath, S Pettersson, K H Meyer zum Büschenfelde, et al.
Frontiers in Immunology|July 19, 2017
Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression ProfilesFriederike Fuchs, Daniela Schillinger, Raja Atreya, et al.
Pageof 39